Silence Therapeutics Plc - American Depository Share (SLN) earnings
SLN earnings moved a median of +0.94% by the close. Quarterly and annual SLN reports and results, each read against the price at its own news timestamp. Back to the SLN overview →
20 measured SLN earnings events.
Where these SLN earnings landedvs 18 measured SLN earnings reactions
| Middle 50% of SLN earnings reactions | -2.47% to +3.18% |
|---|---|
| Median reaction (to close) | +0.94% |
| Measured reactions | 18 |
Point-in-time · zero look-ahead
Half of the 18 SLN earnings events with a measured close landed between -2.47% and +3.18%; 56% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Silence Therapeutics Reports Second Quarter 2026 Financial and Business Results | Press release | -3.64% | — | |
| Form 10-Q Silence Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -1.44% | -4.40% | |
| Silence Therapeutics Highlights Recent Business Achievements and Reports First Quarter 2026 Financial Results | Press release | -1.44% | -4.40% | |
| Form 10-K Silence Therapeutics For: Dec 31 | SEC filing · Form 10-K | -2.96% | +1.85% | |
| Form 10-Q Southland Holdings, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | — | |
| Form 10-Q Silence Therapeutics For: Sep 30 | SEC filing · Form 10-Q | -3.84% | +3.20% | |
| Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights | Press release | -3.84% | +3.20% | |
| Form 10-Q Southland Holdings, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +4.84% | |
| Form 10-Q Silence Therapeutics For: Jun 30 | SEC filing · Form 10-Q | -5.63% | +0.94% | |
| Silence Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights | Press release | -5.63% | +0.94% | |
| Form 10-Q Southland Holdings, Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.70% | -1.22% | |
| Form 10-Q Silence Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -1.70% | -2.47% | |
| Silence Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights | Press release | -1.70% | -2.47% | |
| Form 10-K/A Silence Therapeutics For: Dec 31 | SEC filing · Form 10-K | -0.40% | +7.22% | |
| Form 10-K Southland Holdings, Inc. For: Dec 31 | SEC filing · Form 10-K | -4.48% | +6.05% | |
| Form 10-K Silence Therapeutics For: Dec 31 | SEC filing · Form 10-K | -3.83% | -4.25% | |
| Silence Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights | Press release | -1.58% | -8.03% | |
| Silence Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights | Press release | +0.00% | +3.14% | |
| Silence Therapeutics Reports First Quarter 2024 Results and Highlights Pipeline Progress | Press release | +4.92% | +1.73% | |
| Silence Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results | Press release | — | -0.11% |
Keep exploring
More SLN: analyst actions → · SEC filings → · SLN overview →